MedDataX Logo

Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section

NCT ID: NCT05117307

Last Updated: 2021-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-01

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cesarean section is one of the most common major surgical procedures performed worldwide,, Post-cesarean analgesia should provide adequate pain control while allowing the mother to remain active to meet the needs of the baby. Insufficient analgesia after cesarean section may be associated with acute postoperative pain, chronic pain, higher opioid consumption, delayed functional capacity, and postpartum depression. Techniques such as neuraxial techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to evaluate analgesic consumption.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group ESP

Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side

Group Type ACTIVE_COMPARATOR

Bupivacaine 0.25% Injectable Solution

Intervention Type DRUG

Ultrasound-guided block with 20 ml %0.25 bupivacaine, per side

Group TFP

Ultrasound-guided Transversalis Fascia Plane Block block with 20 ml %0.25 bupivacaine, per side

Group Type ACTIVE_COMPARATOR

Bupivacaine 0.25% Injectable Solution

Intervention Type DRUG

Ultrasound-guided block with 20 ml %0.25 bupivacaine, per side

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine 0.25% Injectable Solution

Ultrasound-guided block with 20 ml %0.25 bupivacaine, per side

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 18-50 years
* Cesarean Section

Exclusion Criteria

* Cesarean Section under general anesthesia
* emergency cases
* those with a body mass index greater than 35 kg/m2
* coagulopathy
* local infection
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erzurum Regional Training & Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Omer Doymus

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Erzurum Regional Training and Research Hospital

Erzurum, Yakutiye, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Omer Doymus, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TFP vs ESP on C/S

Identifier Type: -

Identifier Source: org_study_id